Trial Profile
Effect of Liraglutide or Exenatide Added to a Background Treatment of Metformin, Sulphonylurea or a Combination of Both on Glycaemic Control in Subjects With Type 2 Diabetes.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Oct 2021
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary) ; Exenatide
- Indications Obesity; Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms LEAD-6
- Sponsors Novo Nordisk
- 14 Jul 2016 Results of a meta-analysis in African-American/black people with T2DM from seven phase III trials (NCT00395746, NCT00614120, NCT00294723, NCT00333151, NCT00331851, NCT00518882 and NCT00700817), published in the Diabetic Medicine
- 23 Jun 2012 Planned number of patients changed from 434 to 723 as reported by European Clinical Trials Database.
- 25 Jun 2011 Results from an extension trial presented at the 71st Annual Scientific Sessions of the American Diabetes Association (ADA-2011) (poster 1117-P).